Market Access

The end of anther year is an appropriate time to highlight the march of time-and the transitions that accompany it

Proving that one good turn deserves another, Pfizer and GlaxoSmithKline announced that they would provide millions of doses of pneumonia vaccines to some of the world's most impoverished countries at massive discounts.

The latest buzzword in pharma is "transparency"

A close look at the healthcare industry will separate real cost-cutting measures from money-saving myths.

The former health secretary offers a reality check on healthcare reform-and what to expect from the pols in '09

Congressional leaders ready campaign to curb Medicare drug plans.

A little-known provision in a new law rewards employees for blowing the whistle on tax fraud. Pharma should examine its tricky tax situation-and work out the issues on a global level.

The Medicare Modernization Act set the stage for rapid and easy conversion to government-controlled pricing and the adoption of government pricing by private payers.